Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Letter

CAA-ri and ARIA: Two Faces of the Same Coin?

M. Zedde, R. Pascarella and F. Piazza
American Journal of Neuroradiology February 2023, 44 (2) E13-E14; DOI: https://doi.org/10.3174/ajnr.A7759
M. Zedde
aNeurology Unit, Stroke UnitAzienda Unità Sanitaria Locale-IRCCS di Reggio EmiliaReggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Zedde
R. Pascarella
bNeuroradiology Unit, iCAβ International NetworkAzienda Unità Sanitaria Locale-IRCCS di Reggio EmiliaReggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R. Pascarella
F. Piazza
cCAA and AD Translational Research and Biomarkers Lab, School of MedicineUniversity of Milano-BicoccaMonza, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F. Piazza
  • Article
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

In their article, Cogswell et al1 offered a valuable critical reflection on the past, present, and future challenges in the application of detection and reporting recommendations for amyloid-related imaging abnormalities (ARIAs) associated with amyloid β (Aβ)-lowering immunotherapy for Alzheimer disease (AD) in real-world clinical settings. Increased evidence suggests that drug-induced ARIAs are the iatrogenic manifestation of cerebral amyloid angiopathy–related inflammation (CAA-ri), a rare autoimmune encephalopathy associated with elevated CSF concentrations of spontaneous anti-Aβ autoantibodies (autoAbs) and transient focal areas of swelling (also known as ARIA-E in clinical trials) and CAA-related microhemorrhage (also known as ARIA-H in clinical trials).2,3

In this framework, research and experience in the comparison of ARIAs and CAA-ri in the past decade indicate 3 main critical considerations: First, evidence from trials is limited to an extremely well-selected and neuroradiologically monitored subpopulation of patients with AD. Therefore, current results may have limited generalizability to the broadened community of AD in real clinical settings. In fact, to minimize the occurrence of ARIA, common exclusion criteria are ≥5 cerebral microbleeds (CMBs), irrespective of their location, any cortical superficial siderosis (cSS), and a history of intracerebral hemorrhage (ICH) at baseline MR imaging. However, CMBs, ICH, and cSS do not completely account for the neuroradiologic semiology of small vessel diseases. Given the well-known comorbidity of CAA in AD, further research evaluating the combination of microhemorrhage and no hemorrhagic presentations to increase the sensitivity and specificity in the diagnosis and prediction of ARIA may reveal a strategic issue, as recently reported in the improved Boston criteria 2.0 for the diagnosis of CAA.4

Second, the acronym ARIAs was intended to strictly define the occurrence of neuroimaging abnormalities, not to provide information concerning the associated clinical manifestations. Indeed, current rating systems for ARIA have demonstrated no correspondence between the severity of ARIAs and clinical status and a poor capacity in advising about continuing treatment in patients presenting with mild and asymptomatic ARIA-E. The recent natural history study of CAA-ri in a large, multicenter, prospective longitudinal cohort from a real clinical practice highlighted the transient and potentially remitting nature of ARIA-E, with 84% of clinical and neuroimaging recovery within, respectively, 3 and 6 months and 38% of recurrences within 2 years, which were more common when intravenous corticosteroid therapy was suddenly discontinued without a slow oral tapering.2,3

Third, given the lack of samples and data in trials for independent research, the pathophysiologic mechanisms of ARIAs remain largely unknown. According to the ARIA paradox pathophysiologic model, ARIA-E is a complex and multifactorial phenomenon resulting from the imbalance between the autoantibodies-mediated removal of Aβ from plaques and the downstream effects that an excessive mobilization of the protein can cause on intramural periarterial drainage pathways and neuroinflammation. This hypothesis has been recently investigated in a longitudinal case series of CAA-ri showing a regional and temporal association between ARIA-E and microglial activation and the CSF levels of autoAbs.2 Most interesting, this study also showed that current ARIA-E rating systems alone might not fully capture the complex underlying biology of the phenomenon, suggesting that the combination of MR imaging markers and fluid-based biomarkers can increase the capacity to perform a correct diagnosis. To this end, high levels of autoAbs at baseline may constitute a risk factor, and the CSF testing for autoAbs may meet the specific requirement of companion diagnostic biomarkers for drug tailoring based on the individual risk for iatrogenic CAA-ri. Taken together, this evidence suggests that iatrogenic ARIA-E can be part of the increasingly recognized inflammatory spectrum in Aβ-driven pathologies of aging and that the current diagnosis of spontaneous and iatrogenic CAA-ri can be missed if not properly investigated.4

Increased understanding of the biology of ARIA should reveal a strategic area of research because it could advance the design of second generations of therapeutics and the discovery of the safety and response-to-treatment biomarkers to improve how we currently report, treat, and manage spontaneous and iatrogenic CAA-ri.

Then, a multidisciplinary and interdisciplinary joint effort among neuroradiology, clinical, and translational researchers has never been so important. A common research strategy for ARIA and CAA-ri could reveal strategic information to advance current knowledge gaps and issues in the field, including providing convincing plans for the treatment and management of ARIA when these drugs enter real clinical practice. Only by working together will we really make progress.

Footnotes

  • Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org.

References

  1. 1.↵
    1. Cogswell PM,
    2. Barakos JA,
    3. Barkhof F, et al
    . Amyloid-related imaging abnormalities with emerging Alzheimer disease therapeutics: detection and reporting recommendations for clinical practice. AJNR Am J Neuroradiol 2022;43:E19–35 doi:10.3174/ajnr.A7586 pmid:35953274
    Abstract/FREE Full Text
  2. 2.↵
    1. Piazza F,
    2. Caminiti SP,
    3. Zedde M, et al
    . Association of microglial activation with spontaneous ARIA-E and CSF levels of anti-Aβ autoantibodies. Neurology 2022;99:e1265–77 doi:10.1212/WNL.0000000000200892 pmid:35940900
    Abstract/FREE Full Text
  3. 3.↵
    1. Antolini L,
    2. DiFrancesco JC,
    3. Zedde M, et al
    . Spontaneous ARIA-like events in cerebral amyloid angiopathy-related inflammation: a multicenter prospective longitudinal cohort study. Neurology 2021;97:e1809–22 doi:10.1212/WNL.0000000000012778 pmid:34531298
    Abstract/FREE Full Text
  4. 4.↵
    1. Charidimou A,
    2. Boulouis G,
    3. Frosch MP, et al
    . The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 2022;21:714–25 doi:10.1016/S1474-4422(22)00208-3 pmid:35841910
    CrossRefPubMed
  • © 2023 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 44 (2)
American Journal of Neuroradiology
Vol. 44, Issue 2
1 Feb 2023
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
CAA-ri and ARIA: Two Faces of the Same Coin?
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
M. Zedde, R. Pascarella, F. Piazza
CAA-ri and ARIA: Two Faces of the Same Coin?
American Journal of Neuroradiology Feb 2023, 44 (2) E13-E14; DOI: 10.3174/ajnr.A7759

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
CAA-ri and ARIA: Two Faces of the Same Coin?
M. Zedde, R. Pascarella, F. Piazza
American Journal of Neuroradiology Feb 2023, 44 (2) E13-E14; DOI: 10.3174/ajnr.A7759
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref (10)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS)
    Rosario Pascarella, Katherina Antonenko, Grégoire Boulouis, Hubert De Boysson, Caterina Giannini, Mirjam R Heldner, Odysseas Kargiotis, Thanh N Nguyen, Claire M Rice, Carlo Salvarani, Antje Schmidt-Pogoda, Daniel Strbian, Salman Hussain, Marialuisa Zedde
    European Stroke Journal 2023 8 4
  • Three major effects of APOEε4 on Aβ immunotherapy induced ARIA
    Kate E. Foley, Donna M. Wilcock
    Frontiers in Aging Neuroscience 2024 16
  • Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy
    Louise Kelly, Christopher Brown, Daniel Michalik, Cheryl A. Hawkes, Roxana Aldea, Nivedita Agarwal, Rami Salib, Aiman Alzetani, Douglas W Ethell, Scott E. Counts, Mony de Leon, Silvia Fossati, Maya Koronyo‐Hamaoui, Fabrizio Piazza, Steven A. Rich, Frank J. Wolters, Heather Snyder, Ozama Ismail, Fanny Elahi, Steven T. Proulx, Ajay Verma, Hilary Wunderlich, Mareike Haack, Jean Cosme Dodart, Norman Mazer, Roxana O. Carare
    Alzheimer's & Dementia 2024 20 2
  • Tumor-like Lesions in Primary Angiitis of the Central Nervous System: The Role of Magnetic Resonance Imaging in Differential Diagnosis
    Marialuisa Zedde, Manuela Napoli, Claudio Moratti, Claudio Pavone, Lara Bonacini, Giovanna Di Cecco, Serena D’Aniello, Ilaria Grisendi, Federica Assenza, Grégoire Boulouis, Thanh N. Nguyen, Franco Valzania, Rosario Pascarella
    Diagnostics 2024 14 6
  • Advances in Stroke: Brain Health in 2023
    Tatjana Rundek, Christopher L.H. Chen
    Stroke 2023 54 11
  • Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease
    Marialuisa Zedde, Fabrizio Piazza, Rosario Pascarella
    Journal of Clinical Medicine 2025 14 5
  • Ethical Issues Around Treatment-Induced Amyloid-Related Imaging Abnormalities in Alzheimer's Disease
    Timothy Daly
    Journal of Radiology Nursing 2024 43 3
  • Mouse models of Anti-Aβ immunotherapies
    Philip Pikus, R. Scott Turner, G. William Rebeck
    Molecular Neurodegeneration 2025 20 1
  • Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review
    Marialuisa Zedde, Fabrizio Piazza, Rosario Pascarella
    Applied Sciences 2025 15 7
  • Reference Module in Neuroscience and Biobehavioral Psychology
    Nikita Jain, Samuel N. Lockhart, James R. Bateman
    2024

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire